REACTIVE OXYGEN SPECIES IN HUMAN HEART FAILURE

人类心力衰竭中的活性氧

基本信息

  • 批准号:
    7606214
  • 负责人:
  • 金额:
    $ 0.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-01-03 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall hypothesis of this proposal is that increased oxidative stress contributes to the pathogenesis of human heart failure. The purpose of this study is to test the hypothesis that systemic oxidative stress is increased in patients with systolic heart failure, and is associated with more rapid disease progression. In 100 patients with LV systolic dysfunction, we will measure 8-isoprostanes in the blood as a marker of systemic oxidative stress at baseline and annually for 3 years. We will correlate 9-isoprostanes with cardiac troponin I (cTnI), a measure of ongoing myocardial damage, and LV end-diastolic volume (LVEDV) by magnetic resonance imaging, a measure of structural remodeling. In addition, we will test the hypothesis that polymorphisms of manganese superoxide disumtase (MnSOD), the major SOD in the myocardium, lead to increased oxidative stress and more rapid disease progression in patients with heart failure. In patients studied in Aim 1 we will determine the presence of the -9Ala/Val polymorphism of MnSOD that has been associated with reduced enzyme activity. The presence of this polymorphism will be correlated to 8-isoprostanes and remodeling markers from Aim 1.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Flora Sam其他文献

Flora Sam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Flora Sam', 18)}}的其他基金

Mechanistic underpinnings of increased adipose tissue in HFpEF
HFpEF 中脂肪组织增加的机制基础
  • 批准号:
    10181027
  • 财政年份:
    2019
  • 资助金额:
    $ 0.03万
  • 项目类别:
Mechanistic underpinnings of increased adipose tissue in HFpEF
HFpEF 中脂肪组织增加的机制基础
  • 批准号:
    10444973
  • 财政年份:
    2019
  • 资助金额:
    $ 0.03万
  • 项目类别:
Role of Aldosterone and Adiponectin in Inter-Tissue Communication in Diastolic He
醛固酮和脂联素在舒张期肝组织间通讯中的作用
  • 批准号:
    8583804
  • 财政年份:
    2013
  • 资助金额:
    $ 0.03万
  • 项目类别:
Role of Aldosterone and Adiponectin in Inter-Tissue Communication in Diastolic He
醛固酮和脂联素在舒张期肝组织间通讯中的作用
  • 批准号:
    9067519
  • 财政年份:
    2013
  • 资助金额:
    $ 0.03万
  • 项目类别:
Role of Aldosterone and Adiponectin in Inter-Tissue Communication in Diastolic He
醛固酮和脂联素在舒张期肝组织间通讯中的作用
  • 批准号:
    8841816
  • 财政年份:
    2013
  • 资助金额:
    $ 0.03万
  • 项目类别:
Follistatin-like 1 and the cardiac secretome in human heart failure
卵泡抑素样 1 和人类心力衰竭中的心脏分泌组
  • 批准号:
    7872344
  • 财政年份:
    2010
  • 资助金额:
    $ 0.03万
  • 项目类别:
Follistatin-like 1 and the cardiac secretome in human heart failure
卵泡抑素样 1 和人类心力衰竭中的心脏分泌组
  • 批准号:
    8062288
  • 财政年份:
    2010
  • 资助金额:
    $ 0.03万
  • 项目类别:
Novel Insights into the Pathogenesis of Light Chain Cardiac Amyloidosis
对轻链心脏淀粉样变性发病机制的新见解
  • 批准号:
    8011456
  • 财政年份:
    2010
  • 资助金额:
    $ 0.03万
  • 项目类别:
Novel Insights into the Pathogenesis of Light Chain Cardiac Amyloidosis
对轻链心脏淀粉样变性发病机制的新见解
  • 批准号:
    7787242
  • 财政年份:
    2010
  • 资助金额:
    $ 0.03万
  • 项目类别:
Role of Aldosterone in Cardiac Remodeling
醛固酮在心脏重塑中的作用
  • 批准号:
    7841118
  • 财政年份:
    2009
  • 资助金额:
    $ 0.03万
  • 项目类别:

相似海外基金

Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
  • 批准号:
    10749672
  • 财政年份:
    2024
  • 资助金额:
    $ 0.03万
  • 项目类别:
Towards widespread use of cardiac MRI using new affordable low magnetic field (0.55T) MRI scanner and AI
使用新型经济实惠的低磁场 (0.55T) MRI 扫描仪和 AI 实现心脏 MRI 的广泛使用
  • 批准号:
    2904562
  • 财政年份:
    2024
  • 资助金额:
    $ 0.03万
  • 项目类别:
    Studentship
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
  • 批准号:
    MR/Y003594/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.03万
  • 项目类别:
    Research Grant
Using Novel Machine Learning Methods to Personalize Strategies for Prevention of Persistent AKI after Cardiac Surgery
使用新颖的机器学习方法制定个性化策略,预防心脏手术后持续性 AKI
  • 批准号:
    10979324
  • 财政年份:
    2024
  • 资助金额:
    $ 0.03万
  • 项目类别:
Investigating the mechanosensitive interplays between genetic control and self-organisation during the emergence of cardiac tissue curvature
研究心脏组织曲率出现过程中遗传控制和自组织之间的机械敏感性相互作用
  • 批准号:
    BB/Y00566X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.03万
  • 项目类别:
    Research Grant
Novel minimally-invasive in-situ 3D bioprinting platform for cardiac regeneration
用于心脏再生的新型微创原位3D生物打印平台
  • 批准号:
    EP/X027287/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.03万
  • 项目类别:
    Fellowship
Postoperative reduction in thrombin generation in cardiac surgery: pathogenesis and evaluation
心脏手术术后凝血酶生成减少:发病机制和评估
  • 批准号:
    23H03001
  • 财政年份:
    2023
  • 资助金额:
    $ 0.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for cardiac fibrosis using a cell removal vaccine
使用细胞去除疫苗开发治疗心脏纤维化的新疗法
  • 批准号:
    23K07504
  • 财政年份:
    2023
  • 资助金额:
    $ 0.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
  • 批准号:
    23K07526
  • 财政年份:
    2023
  • 资助金额:
    $ 0.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了